Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome
- 1 December 1996
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 25 (6) , 916-923
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Renal Effects of Natriuretic Peptide Receptor Blockade in Cirrhotic Rats With AscitesHepatology, 1994
- Antidiuretic Hormone and the Pathogenesis of Water Retention in Cirrhosis with AscitesSeminars in Liver Disease, 1994
- Pathogenesis and Management of the Hepatorenal SyndromeSeminars in Liver Disease, 1994
- Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascitesGastroenterology, 1993
- Plasma Endothelin Immunoreactivity in Liver Disease and the Hepatorenal SyndromeNew England Journal of Medicine, 1992
- Assessment of the renin-angiotensin system in cirrhotic patientsJournal of Hepatology, 1992
- Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosisGastroenterology, 1991
- Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failureGastroenterology, 1989
- Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosisHepatology, 1988
- Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretionEuropean Journal of Clinical Investigation, 1983